147 filings
Page 2 of 8
8-K
c6bthv58v1 zu3
10 Aug 21
Zosano Pharma Reports Second Quarter 2021 Financial Results
4:01pm
8-K
vgu3pwt9
2 Jul 21
Submission of Matters to a Vote of Security Holders
5:17pm
8-K
22as 66lnoitm7j2t
28 Jun 21
Entry into a Material Definitive Agreement
4:44pm
8-K
rn73j74
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
bxfkozhwlb0d59k5
10 Jun 21
Regulation FD Disclosure
4:08pm
8-K
vzzif
1 Jun 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:19pm
8-K
6erdrvlow11kcs2
25 May 21
Departure of Directors or Certain Officers
4:12pm
8-K
8l9z0pel
12 May 21
Zosano Pharma Reports First Quarter 2021 Financial Results
4:02pm
8-K
bdtgp7flsl42bs
26 Apr 21
Other Events
8:10am
8-K
2hpv9zi wvl
13 Apr 21
Other Events
4:33pm
8-K
heurcgmj8th0s6xr nsu
11 Mar 21
Departure of Directors or Certain Officers
4:22pm
8-K
f64c586zs6v 0hx
11 Mar 21
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results
4:10pm
8-K
ich mq9ra
4 Mar 21
Other Events
4:07pm
8-K
66st03fikpusv
22 Feb 21
Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes from FDA
8:37am
8-K
18tr6
1 Feb 21
Zosano Pharma Announces NDA Resubmission Plans Following Type A Meeting with FDA
8:11am
8-K
kt38oknlei 5ajcn6b
6 Jan 21
Other Events
4:16pm
8-K
hs7jd7
4 Jan 21
Zosano Pharma Requests Type A Meeting with the FDA to
4:15pm
8-K
9be01o eult
13 Nov 20
Zosano Pharma Reports Third Quarter 2020 Financial Results
4:08pm
8-K
k4gi4s 026
21 Oct 20
Other Events
8:45am
8-K
lblsg
30 Sep 20
Other Events
5:24pm